The method to automatically formulate an animal feed additive composition, comprises the steps of: - selecting (105) a livestock category indicator, said livestock category indicator being associated with at least one targeted nutrient digestibility index, - defining (110) an animal feed composition representation, comprising at least one raw feed material indicator, - converting (115) the defined animal feed composition representation into an equivalent nutrient feed composition representation, comprising at least one nutrient indicator, - determining (120) a quantity of undigested nutrients, - calculating (125) an animal feed additive composition, and - providing (130), upon a computer interface, the animal feed additive composition calculated.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
The present invention relates to sunscreen compositions containing comprising diethylamino hydroxybenzoyl hexyl benzoate (DHHB) and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect) and sensory attributes.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
The present invention relates to sunscreen compositions containing a triazine based UV-filter such as ethylhexyl triazon (EHT) and diethylhexyl butamido triazone (DBT) and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect).
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
The invention relates to a novel amorphous natamycin, compositions comprising it, the use of amorphous natamycin or of the compositions in food, feed, crop or pharmaceutical products, and a manufacturing process to obtain the amorphous natamycin.
C07H 17/08 - Hétérocycles d'au moins huit chaînons, p. ex. érythromycines
C07H 1/00 - Procédés de préparation des dérivés du sucre
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
A01N 43/90 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant plusieurs hétérocycles déterminants condensés entre eux ou avec un système carbocyclique commun
The present invention provides a combination of at least one carotenoid and inulin for use in affecting the gut microbiota in a subject suffering from IBS. Also provided is a combination of at least one carotenoid and inulin for use in affecting the gut microbiota in a subject suffering from overweight or obesity. The combination can be used as a medicament, a dietary supplement, or a food supplement. Preferably, the combination is for use in affecting the gut microbiota in a human IBS subject or overweight subject in comparison to the administration/consumption of inulin alone and the carotenoid alone.
The computer-implemented method (100) for providing at least one blend digital identifier, representing a materialisable blend, associated with at least two strain digital identifiers, each strain digital identifier being representative of an existing strain for food or beverage product fermentation, comprises: - a step of defining (135) at least one value representative of a post-fermentation food or beverage product performance target, - a step of generating (140) at least one blend digital identifier by a trained generative machine- learning model using as input each value representative of a post-fermentation food or beverage product performance target, - a step of providing (145) at least one of the generated at least one blend digital identifier.
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie
G16C 60/00 - Science informatique des matériaux, c.-à-d. TIC spécialement adaptées à la recherche des propriétés physiques ou chimiques de matériaux ou de phénomènes associés à leur conception, synthèse, traitement, caractérisation ou utilisation
7.
BEVERAGES COMPRISING STABLE GRANULES OF MILLED LUTEIN
A process for forming granules includes the steps of:
a) providing an aqueous solution of at least one modified food starch, a glucose syrup and sucrose;
b) adding a carotenoid selected from the group consisting of lutein and zeaxanthin and any mixture thereof to the solution of step a) to thereby obtain a suspension;
c) milling the suspension of step b) until the following particle size distribution of the milled carotenoid is reached:
D [3,2] in the range of from 0.6 to 1.5 μm, and
D [v, 0.5] in the range of from 1.1 to 3.5 μm, wherein
both D values are as measured by laser diffraction (Malvern Instruments Ltd, Malvern, UK, Mastersizer 3000) according to the Fraunhofer scattering model;
d) spray-granulating the suspension of step c) to obtain the granules; and
e) adding a water-soluble antioxidant.
A23L 5/44 - Adjonction de colorants ou de pigments, p. ex. en combinaison avec des azurants optiques en utilisant des colorants ou des pigments organiques d'origine naturelle, leurs doublons artificiels ou leurs dérivés en utilisant des caroténoïdes ou des xanthophylles
A23L 29/212 - AmidonAmidon modifiéDérivés d'amidon, p. ex. esters ou éthers
A23P 10/30 - Mise en capsules de particules, p. ex. additifs alimentaires
The present invention relates to a genetically modified cell comprising a recombinant nucleic acid sequence and/or a cluster of recombinant nucleic acid sequences encoding a transporter protein and/or a cluster of proteins capable of importing an acceptor oligosaccharide of at least three or four monosaccharide units into said cell, wherein said transporter protein and/or cluster of proteins is selected from the group consisting of mutated lactose permease and ABC-importers or MFS importers from a gram-positive bacterium.
The present invention relates to a genetically modified cell comprising a recombinant nucleic acid sequence and/or a cluster of recombinant nucleic acid sequences encoding a transporter protein and/or a cluster of proteins capable of importing an acceptor oligosaccharide of at least three or four monosaccharide units into said cell, wherein said transporter protein and/or cluster of proteins is selected from the group consisting of mutated lactose permease and ABC-importers or MFS importers from a gram-positive bacterium.
The present invention further relates to a method for producing a oligosaccharide, such as a human milk oligosaccharide (HMO), having at least four monosaccharide units, said method comprising culturing a genetically modified cell according to the present invention in a culture medium with a suitable carbon-source and said acceptor oligosaccharide of at least three monosaccharide units; producing said human milk oligosaccharide (HMO) having at least four monosaccharide units by said genetically modified cell, and retrieving the human milk oligosaccharide (HMO) having at least four monosaccharide units from the culture medium and/or the genetically modified cell.
Dicarboxylic diesters are disclosed having the formula (I):
Dicarboxylic diesters are disclosed having the formula (I):
Dicarboxylic diesters are disclosed having the formula (I):
wherein n is 3, and X is a C2 alkenylene group. Such dicarboxylic diesters are useful for inhibiting the methane production in ruminants.
C12P 19/04 - Polysaccharides, c.-à-d. composés contenant plus de cinq radicaux saccharide reliés entre eux par des liaisons glucosidiques
C07H 3/00 - Composés contenant uniquement des atomes d'hydrogène et des radicaux saccharide, ces radicaux ne comportant que des atomes de carbone, d'hydrogène et d'oxygène
C07H 5/00 - Composés contenant des radicaux saccharide dans lesquels les liaisons carbone-oxygène ont été remplacées par le même nombre de liaisons carbone-hétéro-atomes à des atomes d'halogènes, d'azote, de soufre, de sélénium ou de tellure
C08B 37/00 - Préparation des polysaccharides non prévus dans les groupes Leurs dérivés
C12N 9/42 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons bêta-glucosidiques-1, 4, p. ex. cellulase
C12P 19/14 - Préparation de composés contenant des radicaux saccharide préparés par action d'une carbohydrase, p. ex. par action de l'alpha-amylase
C12P 19/26 - Préparation d'hydrates de carbone contenant de l'azote
Various benefits to intestinal health are made by delivery of an active agent to the colon of an animal, including a human. Active ingredients include of riboflavin, vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, β-carotene, vitamin B1, niacin, vitamin B5, vitamin B6, biotin, vitamin B12, omega-3 fatty acids and combinations thereof. Benefits include increased concentration of at least one short-chain fatty acid its salt thereof in the intestine, increased microbiome diversity in the intestine, increased beneficial bacteria in the intestine, increased the butyrate synthesis pathway in the intestine, improved barrier function of the intestine, reduced redox potential of the gut, reduced amount of gas produced in the intestine; and stimulation of intestinal immune responses.
A61K 31/07 - Composés du rétinol, p. ex. vitamine A
A61K 31/122 - Cétones ayant l'atome d'oxygène lié directement à un cycle, p. ex. quinones, vitamine K1, anthraline
A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
The invention relates to a method for the purification of a neutral or sialylated human milk oligosaccharide (HMO) from a fermentation broth. Moreover, the invention also concerns neutral or sialylated HMOs obtained by the inventive method, as well as its use in food, feed, and medical application.
B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
B01D 69/02 - Membranes semi-perméables destinées aux procédés ou aux appareils de séparation, caractérisées par leur forme, leur structure ou leurs propriétésProcédés spécialement adaptés à leur fabrication caractérisées par leurs propriétés
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
B01J 39/05 - Procédés utilisant des échangeurs organiques sous forme fortement acide
B01J 39/19 - Composés macromoléculaires obtenus autrement que par des réactions ne faisant intervenir que des liaisons carbone-carbone non saturées
C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
C12N 9/38 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons bêta-galactose-glycoside, p. ex. bêta-galactosidase
C12P 19/04 - Polysaccharides, c.-à-d. composés contenant plus de cinq radicaux saccharide reliés entre eux par des liaisons glucosidiques
A composition comprising an acetic acid addition salt of Tetradecylaminocarbonyl-Dab-Val-Dab-OH, a process for preparing a cosmetic composition comprising mixing such a composition with one or more other components and the use of an acetic acid addition salt of Tetradecylaminocarbonyl-Dab-Val-Dab- OH to reduce or eliminate the growth of one or more microorganisms, preferably fungi, within a composition.
A61K 8/33 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'oxygène
A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
A61Q 17/00 - Préparations protectricesPréparations employées en contact direct avec la peau pour protéger des influences extérieures, p. ex. des rayons du soleil, des rayons X ou d'autres rayons nuisibles, des matériaux corrosifs, des bactéries ou des piqûres d'insectes
A01N 33/04 - AminesComposés d'ammonium quaternaire l'atome d'azote étant lié directement à des atomes de carbone aliphatiques ou cycloaliphatiques
A01N 47/28 - Urées ou thiourées contenant les groupes N—CO—N ou N—CS—N
The present invention relates to a composition comprising a water-soluble polyol and an acetic acid and/ or a mandelic acid addition salt of at least one peptide selected from the group of palmitoyl-Lys-Val-Dab-OH and palmitoyl-Lys-Val-Dab-Thr-OH. Furthermore, the invention relates to the peptides as such as well as to the use of an acetic acid and/ or a mandelic acid to prepare the respective acid addition salt of the peptide(s) to increase the solubility and/ or storage stability thereof.
The present invention relates to a composition comprising the acetic acid addition salt of Tetradecylaminocarbonyl-Dab-Val-Dab-OH. Furthermore, the invention relates to the use of acetic acid to prepare an acetic acid addition salt of TDAC-Dab-Val-Dab-OH to increase the storage stability of TDAC-Dab-Val-Dab-OH in a polyol solution.
The computer-implemented method (100) for providing a plurality of concentration ranges for cosmetic ingredients in a cosmetic ingredient composition, under constraint of variety comprises: - a step (105) of inputting at least one cosmetic ingredient digital identifier, - a step (110) of defining a primary target cosmetic ingredient composition property value, - a step (115) of retrieving, from a database, or predicting for each cosmetic ingredient digital identifier, at least one cosmetic ingredient composition property value, - a step (120) of computing, for each cosmetic ingredient digital identifier, a cosmetic ingredient concentration value, - a step (125) of calculating a secondary target cosmetic ingredient composition property value which corresponds to a degraded alternative to the primary target, - a step (130) of determining, for each cosmetic ingredient digital identifier, a cosmetic ingredient concentration value to maximize a distance value from the concentration computed during the step of computing, - a step (135) of providing at least one of the cosmetic ingredient concentration values computed and/or determined.
G16C 20/00 - Chémo-informatique, c.-à-d. TIC spécialement adaptées au maniement des données physicochimiques ou structurelles des particules, des éléments, des composés ou des mélanges chimiques
The present invention relates to a sunscreen composition comprising renewable UV filters, having a maximum mass balanced renewable or renewable carbon content and, at the same time, satisfying the desired properties in terms of high sun protection factor, UVA protection factor, appealing skin feel, and minimal impact on the environment.
G16C 20/00 - Chémo-informatique, c.-à-d. TIC spécialement adaptées au maniement des données physicochimiques ou structurelles des particules, des éléments, des composés ou des mélanges chimiques
21.
METHODS AND USES FOR IMPROVING EGG PRODUCTION AND EGG QUALITY INVOLVING ADMINISTERING FEED COMPRISING MURAMIDASE
The present invention relates to a method of improving egg production and/or egg quality of egg laying birds comprising administering to the birds a composition, an animal feed or an animal feed additive comprising one or more microbial muramidases.
A23K 50/75 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les oiseaux pour la volaille
C12N 9/36 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons bêta-1, 4 de l'acide N-acétylmuramique avec l'acétylamino-2 déoxy-2-D-glucose, p. ex. lysozyme
22.
SUNSCREEN COMPOSITION FOR LACTOBACILLUS AND S. EPIDERMIDIS PROTECTION ON SKIN
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethyl hexyltriazone and butyl methoxydibenzoylmethane for the concomitant protection of skin bacteria of the genus Lactobacillus such as e.g., Lactobacillus crispatus (L. crispatus) and S. epidermidis against UV radiation.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61K 8/35 - Cétones, p. ex. quinones, benzophénone
A61K 8/40 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'azote
A61K 31/277 - NitrilesIsonitriles ayant un cycle, p. ex. vérapamil
A61K 31/53 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec trois azote comme seuls hétéro-atomes d'un cycle, p. ex. chlorazanil, mélamine
A61P 17/16 - Émollients ou protecteurs, p. ex. contre les radiations
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
A61Q 19/00 - Préparations pour les soins de la peau
A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A61K 31/7016 - Disaccharides, p. ex. lactose, lactulose
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
The present invention relates to sunscreen compositions containing as UV filters solely a combination of i) bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and (ii) at least two pigmentary UV-filters, wherein the inorganic UV-filters are surface coated. Said compositions exhibit an appealing skin feel and look.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethyl hexyltriazone and butyl methoxydibenzoylmethane for the protection of skin bacteria of the genus Lactobacillus such as e.g., Lactobacillus crispatus (L. crispatus), preferably in the concomitant presence of S. Epidermidis against UV radiation to foster the maintenance of a healthy skin microbiome upon UV irradiation.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61K 8/35 - Cétones, p. ex. quinones, benzophénone
A61K 8/40 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'azote
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
A61Q 19/00 - Préparations pour les soins de la peau
27.
SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH
The invention relates to a method for the purification of a neutral or sialylated human milk oligosaccharide (HMO) from a fermentation broth. Moreover, the invention also concerns neutral or sialylated HMOs obtained by the inventive method, as well as its use in food, feed, and medical application.
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
C07H 1/08 - SéparationPurification à partir de produits naturels
28.
MONO-SAPONIFACTION OF DIESTERS OF TRIMETHYLHYDROQUINONE AND ITS USE IN THE PROCESS OF MANUFACTURING ESTERIFIED ALPHA-TOCOPHEROL
The present invention relates to the mono-saponification of diesters of 2,3,5-trimethylhydroquinone by a base allowing an advantageous synthesis of esterified alpha-tocopherol. The mono-saponification has been demonstrated to occur very selectively at very high yield.
C07C 67/293 - Préparation d'esters d'acides carboxyliques par modification de la partie hydroxyle de l'ester sans introduction d'un groupe ester par isomérisationPréparation d'esters d'acides carboxyliques par modification de la partie hydroxyle de l'ester sans introduction d'un groupe ester par modification de la taille du squelette carboné
C07C 69/16 - Esters d'acide acétique de composés dihydroxylés
29.
PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN
The present invention relates to a process for the preparation of alkoxylated 2.5-dihydrofuran. The process is carried out in an electrochemical cell reactor with a vertical flow.
The invention relates to a protein sprinkle with an average diameter of 0.50 mm to 1.50 mm comprising milk protein concentrate and from 0.5 to 30 wt. % oil.
The present disclosure spray-dried powders including from 30% to 60% by weight of an oil including polyunsaturated fatty acids (PUFAs) based on a total weight of the spray-dried powder. The spray-dried powder can further include a wall material comprising a monosaccharide, a disaccharide, an oligosaccharide, a polysaccharide, or mixtures thereof, where the weight ratio of oil to wall material is from 0.5 to 2 oil/wall material. The spray-dried powder can also include from 1% to 35% by weight of plant protein isolate, based on the total weight of the spray-dried powder.
A23D 9/007 - Autres huiles ou graisses comestibles, p. ex. huiles pour cuisson caractérisées par des ingrédients autres que des triglycérides d'acides gras
A23D 9/05 - Obtention de produits à écoulement libre
A23G 3/50 - Sucreries, confiseries ou massepainProcédés pour leur fabrication caractérisés par la forme, la structure ou la forme physique, p. ex. produits avec structure supportée
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Chemical and biochemicals for use in the food, feed and beverage industry, not included in other classes; chemical and biochemical substances for preserving foodstuffs. Chemical and biochemical ingredients for use as nutritional additives for medical purposes.
The present invention relates to the use of the use of a blend of sugars comprising psicose, mannose, fructose and glucose to increase the expression of cytokeratin-1 in skin to strengthen skin's self-defense mechanisms and maintain skin integrity.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; Medicated feed additives for animals; Medicated supplements for foodstuffs for animals; Feed supplements for veterinary use; Feeding stimulants for animals; Medicated animal feed; Medicated additives for animal foods; Probiotic supplements for animals; Enzymes for veterinary purposes; Enzyme dietary supplements for animals; Amino acids for veterinary purposes; Protein supplements for animals; Bacterial preparations for veterinary purposes; Herbal detoxification agents for animals; Mineral dietary supplements for animals; Nutritional supplements for livestock feed; Food supplements for farm animals; Nutritional supplements for veterinary use. Animal foodstuffs; Mixed animal feed; Formula animal feed; Animal feed preparations; Yeast for animal fodder.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; Medicated feed additives for animals; Medicated supplements for foodstuffs for animals; Feed supplements for veterinary use; Feeding stimulants for animals; Medicated animal feed; Medicated additives for animal foods; Probiotic supplements for animals; Enzymes for veterinary purposes; Enzyme dietary supplements for animals; Amino acids for veterinary purposes; Protein supplements for animals; Bacterial preparations for veterinary purposes; Herbal detoxification agents for animals; Mineral dietary supplements for animals; Nutritional supplements for livestock feed; Food supplements for farm animals; Nutritional supplements for veterinary use. Animal foodstuffs; Mixed animal feed; Formula animal feed; Animal feed preparations; Yeast for animal fodder.
The present invention relates to protein isolate comprising at least 80% of protein on dry weight comprising pea protein and rapeseed protein, wherein the ratio of pea protein to rapeseed protein is within the range of 70:30 to 95:5 (w/w).
The method (100) for providing a plurality of localized values representative of quantities of at least one facial microbiome taxa, said values being associated with facial coordinates comprises the steps of: - collecting (105) a microbiome sample on a facial site associated with facial coordinates, - measuring (110) an absolute quantity of a facial microbiome taxon in said microbiome sample, via a real-time polymerase chain reaction analysis of the collected microbiome sample, - calculating (115) at least one value representative of a quantity of facial microbiome taxa, each calculated value being associated with facial coordinates as a function of the measured absolute quantity of facial microbiome taxon, the coordinates associated with said calculated at least one value being different from the coordinates associated with the collected microbiome sample, and - providing (120) at least one calculated value of facial microbiome taxa and the associated facial coordinates.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
39.
COMPOSITIONS COMPRISING VITAMIN B12 OR VITAMIN B6 AND A MEDIUM CHAIN FATTY ACID
The present invention relates to a combination of a vitamin B selected from cobalamin and or vitamin B6, and a medium chain fatty acid or a salt thereof, and compositions comprising the combination.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
medical diagnostic reagents and tests for body fluids testing; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations and reagents for medical and home use, namely, in-vitro diagnostic preparations and reagents for hormone testing; hormone testing kits for home use
The present invention relates to a new coating system useful for coating particles, which comprise an active ingredient. Such coated particles, when consumed, do show a controlled release in the human or animal body.
Bifidobacterium bifidum (B.bifidum) B. bifidum B. bifidum HA-132 strain (CNCM I-5898) or a strain having at least 97% average nucleotide identity with CNCM I-5898, and the at least one HMO is a sialyllactose.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
The present invention relates to emulsions containing at least one sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties.
A61K 8/98 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés d'origine animale
A61K 8/55 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant du phosphore
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
The present invention relates to compositions containing at least one sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties.
Bifidobacterium bifidumBifidobacterium bifidum (B. bifidum) R0071 strain (CNCM I-3426) or a strain having at least 97% average nucleotide identity with bacteria of said strain, and the mixture of HMOs comprises or consists essentially of 2'- fucosyllactose (2'-FL) and at least one additional HMO selected from an additional fucosylated HMO, a neutral core HMO, and/or a sialylated HMO. The invention also relates to the nutritional composition for use in supporting or improving gut health, immune system development and anti-inflammatory support, cognitive development, and/or emotional and behavioral development, in a subject.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
46.
NUTRITIONAL COMPOSITION COMPRISING BIFIDOBACTERIUM LONGUM SSP. INFANTIS R0033 AND HUMAN MILK OLIGOSACCHARIDES
The invention relates to a nutritional composition comprising a probiotic and a mixture of human milk oligosaccharides (HMOs), wherein the probiotic is the Bifidobacterium longum ssp. infantis R0033 strain (CNCM I-3424) or a strain having at least 97% average nucleotide identity with CNCM I-3424, and the mixture of HMOs comprises or consists essentially of 2'-fucosyllactose (2'-FL) and at least one additional HMO selected from an additional fucosylated HMO, a neutral core HMO, and/or a sialylated HMO. The invention further relates to the nutritional composition for use in supporting or improving gut health and/or a healthy immune system and/or cognitive development, such as motor skills, learning, language skills, spatial cognition ability, in a subject.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
47.
PARTICLES COMPRISING BIOTHERAPEUTIC ENCAPSULATED WITH BIODEGRADABLE POLYMER
The present invention allows to reduce the holding time needed to assure viral degradation in feed. In feed, virucidal activity of benzoic acid can be enhanced by essential oils. One embodiment of the invention relates to a method of at least partially inactivating African swine fever virus in pig feed, characterized in that benzoic acid is added together with at least one essential oil to pig feed. The preferred essential oils are thymol and eugenol.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The identification of efficient enzymes capable of hydrolysing sucrose in its non-modified form, and which on its own enable the cell to utilize sucrose as a, or as the main and/or sole, carbon and/or energy source, i.e., without the need for multi-gene sucrose utilizing systems comprising several other heterologous polypeptides, such as other enzymes and/or transporters, is highly advantageous, since it allows for cost-effective use of sucrose in large scale production processes.
C12P 19/04 - Polysaccharides, c.-à-d. composés contenant plus de cinq radicaux saccharide reliés entre eux par des liaisons glucosidiques
C12N 9/12 - Transférases (2.) transférant des groupes contenant du phosphore, p. ex. kinases (2.7)
C12N 9/26 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2) agissant sur les liaisons alpha-glucosidiques-1, 4, p. ex. hyaluronidase, invertase, amylase
C12N 15/52 - Gènes codant pour des enzymes ou des proenzymes
C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using an improved seed fermentation process.
A method for reducing diarrhea and/or improving fecal quality of animals, comprises administering to the animal a feed composition comprising a) at least one organic acid and/or at least one salt thereof; and b) hypophosphorous acid and/or at least one salt thereof.
The present invention provides a method for reducing diarrhea and/or improving fecal quality of animals, comprising administering to the animal a feed composition comprising a) at least one organic acid and/or at least one salt thereof; and b) hypophosphorous acid and/or at least one salt thereof.
The present invention provides a method for reducing usage dosage of benzoic acid and/or at least one salt thereof for improving growth performance of an animal, comprising administering to the animal a feed composition comprising a) benzoic acid and/or at least one salt thereof, and b) at least one additional organic acid and/or at least one salt thereof.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
10 - Appareils et instruments médicaux
17 - Produits en caoutchouc ou en matières plastiques; matières à calfeutrer et à isoler
Produits et services
unprocessed polyurethane elastomeric material for medical use semi-processed polyurethane, namely, semi-processed polyurethane in powder, liquid, pellet, granule, fabrics, braid, membrane, and woven form
The invention relates to the field of bakery ingredients. More specifically, the invention relates to a variant of a parent polypeptide, wherein the difference between the variant polypeptide and the parent polypeptide is that a KEX2 protease cleavage site which is present in the parent polypeptide, is absent in the variant polypeptide. The invention further relates to a process for preparing a dough wherein a variant polypeptide as disclosed herein is used and baked product prepared from the dough.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
Produits et services
Hydrocolloids, gelling agents, thickening agents, stabilizers, emulsifiers, binding agents, gums, modified starches, pectins and fibers for use in the manufacture of food and beverage products, pharmaceuticals, personal care products and cosmetics.
59.
NEW SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF LST-A
The present disclosure relates to the production of sialylated Human Milk Oligosaccharides (HMOs), in particular to the production of sialyl-lacto-N-tetraose a (LST-a), from precursor oligosaccharides and the genetic engineering of suitable cells for use in said production, as well as to methods for producing said sialylated HMOs.
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p. ex. alpha-, bêta- ou gamma-cyclodextrines
Alpha lipoic acid is employed as a feed additive for aquatic animals including fish and shrimp, especially for cold water fish as for example salmon, bream, bass and for warm water fish as for example carp, tilapia, catfish. More particular, alpha lipoic acid is disclosed herein for the improvement of the feed conversion ratio and/or daily weight gain in fish, for reducing mortality by regulating the micro flora of the gut and/or by protecting the animal against infections caused by pathogenic viruses.
A23K 40/20 - Mise en forme ou traitement des produits alimentaires pour animaux par moulage, p. ex. fabrication de gâteaux ou de briquettes
A23K 40/25 - Mise en forme ou traitement des produits alimentaires pour animaux par extrusion
A23K 40/30 - Mise en forme ou traitement des produits alimentaires pour animaux par encapsulationMise en forme ou traitement des produits alimentaires pour animaux par revêtement
A23K 50/80 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux aquatiques, p. ex. pour les poissons, les crustacés ou les mollusques
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
61.
PREDICTIVE MACHINE LEARNING MODEL TO PROVIDE A SUN PROTECTION FACTOR VALUE (SPF) ASSOCIATED TO AN ULTRAVIOLET (UV) FILTER COMPOSITION
A computer-implemented method (100) for providing at least one predicted Sun Protection Factor (SPF) value associated to an Ultraviolet (UV) filter composition comprising: - a step of providing (135) an original set of exemplar UV filter composition digital identifiers, said set of exemplar UV filter composition, comprising for at least one UV filter composition digital identifiers: - at least one existing ingredient or at least one combination of existing ingredients, - at least one calculated UV spectrum, and - a value representative of an empirically measured SPF value, to form a training set, - a step of training (140) a predictive machine-learning model using the training set, to predict at least one SPF value, - a step of defining (145) at least one UV filter composition digital identifier, - a step of predicting (150) at least one SPF value using the trained predictive machine-learning model and - a step of providing (155) the predicted SPF value.
G16C 20/00 - Chémo-informatique, c.-à-d. TIC spécialement adaptées au maniement des données physicochimiques ou structurelles des particules, des éléments, des composés ou des mélanges chimiques
G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
62.
COMBINATION OF MIXTURES OF HMOS WITH MFGM AND THEIR USE
The present disclosure relates compositions comprising milk fat globule membrane (MFGM) and a mixture of HMOs with at least one fucosylated HMO and at least one HMO selected from neutral core HMOs or sialylated HMOs. The compositions have potential health benefits in terms of improving gut health, immunity and appetite regulation, by increasing the formation of propionic acid.
The present disclosure relates compositions comprising milk fat globule membrane (MFGM) and a mixture of HMOs with at least one fucosylated HMO and at least one HMO selected from neutral core HMOs or sialylated HMOs. The compositions have potential health benefits in terms of improving brain health, immunity and recovery time following exercise, by increasing the formation of glutamic acid.
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
45 - Services juridiques; services de sécurité; services personnels pour individus
Produits et services
Business assistance and administrative services in the
pharmaceutical field; supply chain management services in
relation to the pharmaceutical field; retail and wholesale
of ingredients for pharmaceuticals. Consultancy relating to pharmaceutical research and
development. Pharmaceutical consultation. Legal services and advice in relation to compliance
regulations in the pharmaceutical field; consultation in
relation to compliance in the pharmaceutical field;
regulatory compliance consulting and auditing services for
the pharmaceutical industry; reviewing standards and
practices to assure compliance with local laws and
regulation in relation to the pharmaceutical field.
The invention disclosed herein relates generally to the field of recombinant production of a steviol glycoside, to the field of bioconversion of steviol into a steviol glycoside and to the field of bioconversion of a steviol glycoside into a further steviol glycoside. Particularly, the invention provides a process for recombinant production of a steviol glycoside, a process of bioconversion of steviol into a steviol glycoside, a process for bioconversion of a steviol glycoside into a further steviol glycoside and a composition comprising a steviol glycoside. More particularly, the invention relates to a microorganism that has a deficiency of a serine/threonine protein kinase and comprises a polynucleotide encoding a polypeptide having uridine diphosphate-dependent glucosyltransferase (UGT) activity.
C12N 15/81 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons pour levures
C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
C12N 9/04 - Oxydoréductases (1.), p. ex. luciférase agissant sur des groupes CHOH comme donneurs, p. ex. oxydase de glucose, déshydrogénase lactique (1.1)
C12P 19/56 - Préparation d'O-glucosides, p. ex. glucosides avec un atome d'oxygène du radical saccharide lié directement à un système cyclique condensé d'au moins trois carbocycles, p. ex. daunomycine, adriamycine
66.
HMO PRODUCING MICROORGANISM WITH INCREASED ROBUSTNESS TOWARDS GLUCOSE GRADIENTS
The present disclosure relates to improved strains for the production of Human Milk Oligosaccharides (HMOs) in large scale. The strains are genetically engineered to produce less acetate and/or ethanol during large-scale fermentation, in particular when encountering gradients with excess carbon source in the fermenter.
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p. ex. alpha-, bêta- ou gamma-cyclodextrines
The present disclosure relates to alpha-1,2-fucosyltransferase variants with reduced alpha-1,3- fucosyltransferase activity and genetically engineered cells comprising an alpha-1,2- fucosyltransferase variant for the biosynthetic production of 2'FL. Use of the variants and the genetically engineered cells in the production of 2'-fucosyllactose (2'FL) with reduced amounts of the by-product difucosyllactose (DFL).
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p. ex. alpha-, bêta- ou gamma-cyclodextrines
68.
MODEL-BASED DETECTION OF DEFICIENCY IN ANIMAL'S NUTRITIONAL STATE
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23K 20/147 - Dérivés polymériques, p. ex. peptides ou protéines
A composition comprising benzoic acid, derivatives or metabolites thereof, in combination with at least one essential oil selected from the group consisting of thymol, eugenol and piperine, for improving growth performance of an animal infected with Streptococcus suis.
A graft includes a tube having an inner film layer, an outer film layer disposed radially outward of the inner film layer, and a radiopaque element disposed between the inner film layer and the outer film layer. The radiopaque element may include a polymer material having a radiopacifier material contained therein, and the radiopacifier material imparts radiopacity to the radiopaque element. The graft may further include a reinforcing element disposed between the inner film layer and the outer film layer and/or a middle film layer disposed between the outer film layer and the inner film layer. The reinforcing element and the radiopaque element may be positioned on opposite sides of the middle film layer.
The present invention provides a method for reducing ammonia emission of aquatic animals comprising administering to the animals one or more proteolytic enzymes, i.e., proteases. The present invention also provides a feed composition suitable for the above methods and use thereof.
A23K 50/80 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux aquatiques, p. ex. pour les poissons, les crustacés ou les mollusques
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; feed additives for animals;
medicated supplements for foodstuffs for animals; feed
supplements for veterinary use; feeding stimulants for
animals; medicated animal feed; medicated additives for
animal foods; probiotic supplements for animals; enzymes for
veterinary purposes; enzyme dietary supplements for animals;
amino acids for veterinary purposes; protein supplements for
animals; bacterial preparations for veterinary purposes;
herbal detoxification agents for animals; mineral dietary
supplements for animals; nutritional supplements for
livestock feed; food supplements for farm animals;
nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed;
animal feed preparations; yeast for animal fodder.
73.
HMO MIXTURE AND ITS USE IN REDUCING C. DIFFICILE TOXINS
Clostridium difficileBifidobacteriaBifidobacterium longumBifidobacterium adolescentisFaecalibacteriumFaecalibacterium prausnitziiFaecalibacterium prausnitzii in the gut of a subject, in particular an elderly.
The method (100) to automatically assess a vitamin status in the blood of a livestock animal comprises the steps of: locally, collecting (105) a drop of blood from a livestock animal on a carrier, locally, drying (110) the drop of blood of the livestock animal on the carrier, sending (115) the carrier to a remote location, via a transport vessel, said remote location comprising at least one metabolized vitamin assessment device, calculating (120), by a computing device connected to the assessment device in the remote location, a vitamin status value in the blood of the livestock animal on the carrier, determining (125), by a computing device, as a function of the calculated vitamin status value and of a target vitamin metabolite value, a livestock animal vitamin status, and locally, providing (130) the livestock animal vitamin status.
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Chemicals for industrial and scientific purposes; chemical substances for preserving foodstuffs; enzyme preparations for industrial purposes. Fungicides, disinfectants.
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Chemical and organic compositions for use in manufacture of dietary and food supplements; raw materials for the preparation of dietary and food supplements; raw materials for the preparation of medical nutrition; plant extracts for industrial purposes; trigonelline-based compound for use in dietary supplements and medical nutrition. Dietary supplement containing trigonelline; medical nutrition products containing trigonelline; dietary supplements; vitamins and vitamin preparations; vitamin and mineral supplements; vitamin and mineral preparations; plant extracts for medicinal purposes; dietetic food and beverages adapted for medical use; nutraceuticals for use as a dietary supplement.
The present invention relates to a solid formulation comprising lutein with a high amount of a specific stereochemical form. Furthermore, the present invention relates to a process of production of such a specific formulation.
The present invention relates to a solid formulation comprising carotene derivatives, not including β-carotene, with a high amount of a specific stereochemical form. Furthermore, the present invention relates to a process of production of such a specific formulation.
A23L 5/44 - Adjonction de colorants ou de pigments, p. ex. en combinaison avec des azurants optiques en utilisant des colorants ou des pigments organiques d'origine naturelle, leurs doublons artificiels ou leurs dérivés en utilisant des caroténoïdes ou des xanthophylles
A23L 29/212 - AmidonAmidon modifiéDérivés d'amidon, p. ex. esters ou éthers
A23L 29/219 - Amidon chimiquement modifiéProduits de réaction ou de complexation de l’amidon avec d’autres produits chimiques
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
The present invention relates to a process for fermenting Yarrowia in a bioreactor, comprising cultivating Yarrowia in a medium, and adding a feed comprising formic acid and a sugar to the medium in a molar ratio of formic acid to sugar of 1 to 13 mol formic acid/mol monosaccharide.
C12M 1/36 - Appareillage pour l'enzymologie ou la microbiologie comportant une commande sensible au temps ou aux conditions du milieu, p. ex. fermenteurs commandés automatiquement
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
The present invention relates to the use of psicose to suppress the discoloration of vitamin B12 in aqueous compositions. Furthermore, the invention relates to aqueous compositions comprising psicose, Vitamin B12 and optionally one or more preservatives selected from phenoxyethanol, (ethyl)hexylglycerin and/or an 1,2-alkandiol.
The present invention relates to new oligopeptides and derivatives of oligopeptides as well as to their use for the prevention and/ or treatment of skin ageing.
C07K 5/062 - Dipeptides la chaîne latérale du premier amino-acide étant acyclique, p. ex. Gly, Ala
C07K 5/065 - Dipeptides la chaîne latérale du premier amino-acide contenant des carbocycles, p. ex. Phe, Tyr
C07K 5/072 - Dipeptides la chaîne latérale du premier amino-acide contenant plus de groupes carboxyle que de groupes amino, ou leurs dérivés, p. ex. Asp, Glu, Asn
C07K 5/083 - Tripeptides la chaîne latérale du premier amino-acide étant acyclique, p. ex. Gly, Ala
C07K 5/087 - Tripeptides la chaîne latérale du premier amino-acide contenant des carbocycles, p. ex. Phe, Tyr
C07K 5/103 - Tétrapeptides la chaîne latérale du premier amino-acide étant acyclique, p. ex. Gly, Ala
C07K 5/107 - Tétrapeptides la chaîne latérale du premier amino-acide contenant des carbocycles, p. ex. Phe, Tyr
C07K 5/113 - Tétrapeptides la chaîne latérale du premier amino-acide contenant plus de groupes carboxyle que de groupes amino, ou leurs dérivés, p. ex. Asp, Glu, Asn
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Chemicals for use in the manufacture of cosmetics; emollients used for the manufacture of cosmetic products. Cosmetics and cosmetic preparations, also for make-up, beauty, eye care, scalp care, foot care, lip care, hair care, face care, body care, skin care and hand care, Cosmetics, make-up, eye care products, hair care products, scalp care products, foot care products, lip care products, face care products, body care products, skin care products and hand care products for the prevention of sunburn; Sun-tan and sun-screening preparations; sun care preparations.
The present disclosure relates to cheese products comprising partially deacylated gellan gum. The present disclosure also relates to methods for producing the cheese products, and use of partially deacylated gellan gum for improving the texture and/or sensory characteristics of cheese products.
The present invention relates to the increase of water resistance of cosmetic compositions which comprise pigments. This is achieved by the combined use of a mixture of branched and linear saturated C15-C19 alkanes; and an ester of a fatty acid and dextrin.
The present invention relates to the use of a blend of sugars comprising psicose, mannose, fructose and glucose to suppress the discoloration of vitamin B12 in aqueous compositions. Furthermore, the invention relates to aqueous compositions comprising said blend, Vitamin B12 and one or more preservatives selected from phenoxyethanol, (ethyl)hexylglycerin and/or an 10 1,2-alkandiol.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
31 - Produits agricoles; animaux vivants
Produits et services
Dietary supplements for animals; animal feed additives for animals use as nutritional supplements; medicated supplements for foodstuffs for animals; feed supplements for veterinary use; feeding stimulants for animals; medicated animal feed; medicated additives for animal foods for use as nutritional supplements; probiotic supplements for animals; enzymes for veterinary purposes; enzyme dietary supplements for animals; amino acids for veterinary purposes; protein supplements for animals; bacterial preparations for veterinary purposes; herbal detoxification agents for animals for medical purposes; mineral dietary supplements for animals; nutritional supplements for livestock feed; food supplements for farm animals; nutritional supplements for veterinary use Animal foodstuffs; mixed animal feed; formula animal feed; yeast for animal fodder
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Feminine deodorant suppositories Dietary supplements; nutritional supplements; vaginal suppositories for the prevention and treatment of infections; vaginal moisturizers; Phenazopyridine hydrochloride preparations in the nature of analgesics; Methenamine and Sodium Salicylate preparations in the nature of analgesics and antibacterial substances for medical purposes; medicinal preparations for the treatment of yeast infections; homeopathic medicine for use in the treatment of bacterial, yeast, and urinary tract infections; diagnostic test kits comprised of medical diagnostic test strips and color chart for use in diagnosing urinary tract infections; diagnostic test kit comprised of cotton swabs for medical purposes and pH self-test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; medical diagnostic reagents and tests being medical diagnostic assays, in vivo diagnostic preparations and reagents for hormone testing, and hormone testing kits for home use, all for body fluids testing; chemically treated paper for use in the detection of the vaginal pH for medical purposes; cotton swabs for medical purposes
88.
NEW FERMENTED MILK PRODUCT AND PROCESS FOR PRODUCTION THEREOF
A fermented milk product, wherein the fermented milk product comprises:
a porous protein network;
a first, capsular, preferably negatively charged, exopolysaccharide; and
a second, non-capsular, preferably neutral, exopolysaccharide.
A fermented milk product, wherein the fermented milk product comprises:
a porous protein network;
a first, capsular, preferably negatively charged, exopolysaccharide; and
a second, non-capsular, preferably neutral, exopolysaccharide.
A starter culture comprising a first, preferably negatively charged, capsular, exopolysaccharide producing lactic acid bacterial strain and a second, preferably neutral, non-capsular, exopolysaccharide producing lactic acid bacterial strain, wherein the weight ratio of the weight of the first exopolysaccharide producing lactic acid bacterial strain to the weight of the second exopolysaccharide producing lactic acid bacterial stain in the starter culture lies in the range from equal to or more than 1:1 to equal to or less than 100:1, more preferably in the range from equal to or more than 10:1 to equal to or less than 100:1; and a use thereof and process using such.
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
The invention relates to a protein bar comprising 20 to 70 wt. % of a binder, water, pea protein and rapeseed protein, wherein the sum of the pea protein and rapeseed protein is at least 20 wt. % of the protein bar.
Cosmetic compositions are disclosed which comprise a hyperbranched copolymer of the monomers dodecenyl succinic acid anhydride, diisopropanol amine and bis-dimethylaminopropyl amine having quaternary terminal groups and an oil with a polarity index of either in the range of 50-30 mN/m or in the range of 18-5 mN/m. Material transfer of the cosmetic sun care composition from a skin surface to which the cosmetic sun care composition is applied to another surface contacted by the skin surface is substantially less as compared to an identical cosmetic sun care composition which does not comprise the hyperbranched copolymer.
The present invention is directed to a composition comprising rapeseed protein, a hydrocolloid, and a vegetable oil, and to the use of such composition in food products such as a beverage.
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
92.
A METHOD FOR PROVIDING AN AMORPHOUS HMO PRODUCT BY DRYING
A method for providing a solid amorphous HMO product, said method including drying an aqueous composition of said HMO. Solid amorphous HMO product is obtained via said method, as well as solid amorphous HMO product per se.
The present invention relates to cosmetic composition comprising UV-filter(s), an ester of a fatty acid and dextrin and a mixture of branched and linear saturated C15-C19, wherein said mixture comprised primarily branched saturated C15-C19 and a specific cellulose derivative. This cosmetic composition shows a significantly increased water resistance.
A61K 8/40 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant de l'azote
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
The present invention relates to methods of reducing material transfer of cosmetic compositions which include at least one liquid dispersion of an acrylic polymer by incorporating into the cosmetic compositions an amount of a hyperbranched copolymer sufficient to reduce material transfer of the cosmetic composition, wherein the hyperbranched copolymer is a copolymerization reaction product of the monomers dodecenyl succinic acid anhydride, diisopropanol amine and bis-dimethylaminopropyl amine having quaternary terminal groups and at least one liquid dispersion of an acrylic polymer which is a homopolymer or a copolymer of the monomers selected from the group consisting of (meth)acrylic acid, (meth)acrylic esters, (meth)acrylamide and amides of (meth)acrylic acid.
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
The present disclosure relates generally to the production of glycosylated compounds. Provided is a recombinant cell and a method for enzymatically modifying a glycosyl acceptor. The method comprises contacting a recombinant cell producing sucrose with a glycosyl acceptor and 5 at least one enzyme capable of catalyzing the transfer of a glycosyl group from sucrose to the glycosyl acceptor; thereby producing a modified glycosyl acceptor. Also provided is a composition obtainable by a method of the disclosure, and the use thereof.
C12P 19/56 - Préparation d'O-glucosides, p. ex. glucosides avec un atome d'oxygène du radical saccharide lié directement à un système cyclique condensé d'au moins trois carbocycles, p. ex. daunomycine, adriamycine
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p. ex. alpha-, bêta- ou gamma-cyclodextrines
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
A23K 50/30 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les porcs
A23K 50/75 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les oiseaux pour la volaille
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
97.
CELLS AND METHODS FOR THE PRODUCTION OF GLYCOSYLATED COMPOUNDS
The present disclosure relates generally to the production of glycosylated compounds. Provided is a recombinant cell and a method for enzymatically modifying a glycosyl acceptor. The method comprises contacting a glycosyl donor and a glycosyl acceptor with a recombinant cell comprising a heterologous enzyme capable of catalyzing the transfer of a glycosyl group from the glycosyl donor to the glycosyl acceptor; thereby producing a modified glycosyl acceptor. Also provided is a composition obtainable by a method of the disclosure, and the use thereof.
C12P 19/56 - Préparation d'O-glucosides, p. ex. glucosides avec un atome d'oxygène du radical saccharide lié directement à un système cyclique condensé d'au moins trois carbocycles, p. ex. daunomycine, adriamycine
C12P 19/18 - Préparation de composés contenant des radicaux saccharide préparés par action d'une transférase glycosylique, p. ex. alpha-, bêta- ou gamma-cyclodextrines
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
45 - Services juridiques; services de sécurité; services personnels pour individus
Produits et services
Business assistance and administrative services in the pharmaceutical field; supply chain management services in relation to the pharmaceutical field Consultancy relating to pharmaceutical research and development Pharmaceutical consultation Legal services and advice in relation to compliance regulations in the pharmaceutical field; consultation in relation to compliance in the pharmaceutical field; regulatory compliance consulting and auditing services for the pharmaceutical industry; reviewing standards and practices to assure compliance with local laws and regulation in relation to the pharmaceutical field
The present invention relates sunscreen compositions comprising ethylhexyl triazone and 2-ethylhexyl 2-hydroxycyclohexanecarboxylate as well as to the use of 2-ethylhexyl 2-hydroxycyclohexanecarboxylate as effective solubiliser for ethylhexyl triazone.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
The present invention relates sunscreen compositions comprising 2-ethylhexyl 2-hydroxycyclohexanecarboxylate, bis-ethylhexyloxyphenol methoxyphenyl triazine and at least one UV-filter selected from butyl methoxy dibenzoyl methane, diethylamino hydroxybenzoyl hexyl benzoate and ethylhexyl triazone as well as to the use of butyl methoxy dibenzoyl methane, diethylamino hydroxybenzoyl hexyl benzoate and/ or ethylhexyl triazone to increase the solubility of bis-ethylhexyloxyphenol methoxyphenyl triazine in 2-ethylhexyl 2-hydroxycyclohexanecarboxylate.
A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer